Targeted Therapy for Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeted Therapy for Cancer

Gastrointestinal stromal tumors (GISTs) are unique tumors, arising largely due to oncogenic mutations in KIT or PDGFRA tyrosine kinases. Although surgery remains the most effective treatment, the remarkable clinical success…

read more

Translational Research in Melanoma

Sep 27, 2017 by in ONCOLOGY Comments Off on Translational Research in Melanoma

Recent breakthroughs in the fundamental understanding of the cellular and molecular basis of melanoma have culminated in new therapies with unquestionable efficacy. Immunotherapy and targeted therapy strategies have completely transformed…

read more

Cancer Immunotherapy

Sep 27, 2017 by in ONCOLOGY Comments Off on Cancer Immunotherapy

Better understanding of the underlying principles of tumor biology and immunology, enhanced by recent insights into the mechanisms of immune recognition, regulation, and tumor escape has provided new approaches for…

read more

Targeting the p53 Pathway

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the p53 Pathway

This article summarizes data on translational studies to target the p53 pathway in cancer. It describes the functions of the p53 and Mdm-2 signaling pathways, and discusses current therapeutic approaches…

read more

Targeting the NF-κB Pathway in Cancer Therapy

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the NF-κB Pathway in Cancer Therapy

Most NF-κB inhibitors target the IKK complex, IκB proteins, or NF-κB transcription factors. The most promising classes of inhibitors include antioxidants, antiinflammatory compounds, natural compounds, statins, proteasome inhibitors, IKKβ inhibitors,…

read more

Targeting Receptor Tyrosine Kinases in Solid Tumors

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting Receptor Tyrosine Kinases in Solid Tumors

Tyrosine kinase (TK) cascades are involved in all stages of tumorigenesis through modulation of transformation and differentiation, cell-cycle progression, and motility. Advances in molecular targeted drug development allow the design…

read more

Targeting the Heat Shock Response in Cancer

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the Heat Shock Response in Cancer

The elucidation of the heat shock response (HSR) as a mediator of cellular stress has created a framework for understanding how these processes may promote tumorigenesis. Furthermore, the identification of…

read more

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

This article presents an overview of the PI3K/Akt/mTOR signaling pathway. As a central regulator of cell growth, protein translation, survival, and metabolism, activation of this signaling pathway contributes to the…

read more

Targeting Angiogenesis and the Tumor Microenvironment

Sep 27, 2017 by in ONCOLOGY Comments Off on Targeting Angiogenesis and the Tumor Microenvironment

The role of the microenvironment during the initiation and progression of malignancy is appreciated to be of critical importance for improved molecular diagnostics and therapeutics. The tumor microenvironment is the…

read more

Translational Cancer Research for Surgeons

Sep 27, 2017 by in ONCOLOGY Comments Off on Translational Cancer Research for Surgeons

William G. Cance, MD, Editor Over the last 20 years, we have gained a massive amount of knowledge about the genetic basis of human cancer. Culminating with the sequencing of…

read more
Get Clinical Tree app for offline access